Lidocaine Hydrochloride Injection, USP is a sterile, nonpyrogenic solution formulated as a local anesthetic for infiltration, nerve block, and regional anesthesia. Available in various concentrations, Lidocaine is an amide-type local anesthetic that stabilizes neuronal membranes to inhibit impulse initiation and conduction.
Key Benefits:
- Local and Regional Anesthesia: Effective for producing anesthesia via infiltration, nerve block, and epidural techniques.
- Flexible Concentrations and Formats: Provided in multiple strengths, including single-dose and multiple-dose vials.
- Rapid Onset: Known for quick onset of action, suitable for diverse clinical settings and procedures.
Dosage and Administration:
For Parenteral Use Only, the dosage depends on the procedure type and patient factors:
- Infiltration and Nerve Blocks: Commonly used concentrations range from 0.5% to 2% based on the anesthesia depth required.
- Epidural Anesthesia: Administered in volumes appropriate for the desired dermatomes, typically 1%-2%. Careful monitoring and adherence to maximum dosage recommendations are essential to prevent systemic toxicity.
Why Choose Lidocaine Hydrochloride Injection?
- Versatile Anesthetic Applications: Widely used for localized pain management in minor and major surgical procedures.
- Clinically Trusted: Established efficacy in anesthesia with customizable dosing to match patient needs.
- Safe and Sterile: Manufactured under strict controls, offering both preservative-free and preserved options.
Warnings:
- Risk of Methemoglobinemia: May cause methemoglobinemia, especially in patients with G6PD deficiency or when combined with oxidizing agents.
- Hypersensitivity Reactions: Monitor patients for allergic reactions, particularly those sensitive to amide-type anesthetics.
- Not for Intravenous Injection: Avoid intravenous administration without dilution to prevent adverse cardiovascular effects.
Disclaimer:
This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.